Development of Breast Cancer Prognosis Prediction Model Based on Clinical Features Including CEA and CA15-3 Serum Levels

키워드

참고문헌 (47)

1. Boeri C, "Machine learning techniques in breast cancer prognosis prediction : a primary evaluation", Cancer Med, 9(9), pp.3234~3243 (2020)[DOI]
2. Stark GF, "Predicting breast cancer risk using personal health data and machine learning models", PLoS One, 14(12), pp.e0226765~ (2019)[DOI]
3. Woojae Kim, "Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector Machine", Journal of Breast Cancer, 15(2), pp.230~238 (2012), 한국유방암학회[DOI]
4. Chatterjee SK, "Cancer biomarkers : knowing the present and predicting the future", Future Oncol, 1(1), pp.37~50 (2005)[DOI]
5. Wang J, "Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients", Int J Clin Exp Pathol, 8(11), pp.14853~14863 (2015)[DOI]
6. Hayes DF, "Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer", J Clin Oncol, 4(10), pp.1542~1550 (1986)[DOI]
7. O’Hanlon DM, "Tissue polypeptide specific antigen(TPS)in breast cancer--an initial evaluation", Eur J Surg Oncol, 22(1), pp.38~41 (1996)[DOI]
8. Vizcarra E, "CA 15. 3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse", Oncology, 51(6), pp.491~496 (1994)[DOI]
9. Van Dalen A, "The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease", Int J Biol Markers, 13(1), pp.10~15 (1998)[DOI]
10. Peng Y, "Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer", Int J Clin Exp Med, 8(1), pp.982~990 (2015)
11. Van Dalen A, "Treatment response in metastatic breast cancer. A multicenter study comparing UICC criteria and tumor marker changes", The Breast, 5(2), pp.82~87 (1996)[DOI]
12. Lin JK, "Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer", Int J Colorectal Dis, 26(9), pp.1135~1141 (2011)[DOI]
13. Díez M, "Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer", Br J Cancer, 73(10), pp.1248~1254 (1996)[DOI]
14. Wiwiek Poedjiastoeti, "Application of Convolutional Neural Network in the Diagnosis of Jaw Tumors", Healthcare Informatics Research, 24(3), pp.236~241 (2018), 대한의료정보학회[DOI]
15. Wiharto Wiharto, "Interpretation of Clinical Data Based on C4.5 Algorithm for the Diagnosis of Coronary Heart Disease", Healthcare Informatics Research, 22(3), pp.186~195 (2016), 대한의료정보학회[DOI]
16. Chawla NV, "Editorial : special issue on learning from imbalanced data sets", ACM SIGKDD Exploration Newsletter, 6(1), pp.1~6 (2004)[DOI]
17. Thanathamathee P, "Handling imbalanced data sets with synthetic boundary data generation using bootstrap re-sampling and AdaBoost techniques", Pattern Recogn Lett, 34(12), pp.1339~1347 (2013)[DOI]
18. Park BW, "Preoperative CA15-3 and CEA serum levels as predictor for breast cancer outcomes", Ann Oncol, 19(4), pp.675~681 (2008)[DOI]
19. Kotsiantis SB, "Data preprocessing for supervised leaning", Int J Comput Sci, 1(1), pp.111~117 (2006)[DOI]
20. Ioffe S, "Batch normalization: Accelerating deep network training by reducing internal covariate shift", arXiv 2015;37:448-456. DOI: 10.5555, 2015
21. Yadav ML, "Handling missing values : a study of popular imputation packages in R", Knowl Based Syst, 160, pp.104~118 (2018)[DOI]
22. Elreedy D, "A comprehensive analysis of synthetic minority oversampling technique(SMOTE)for handling class imbalance", Inf Sci, 505, pp.32~64 (2019)[DOI]
23. Efron B., "Breakthroughs in statistics", pp.569~593 (1992), Springer
24. Moody F, "Fast learning in networks of locally-tuned processing units", Neural Comput, 1(2), pp.281~294 (1989)[DOI]
25. Dwivedi AK, "Performance evaluation of different machine learning techniques for prediction of heart disease", Neural Comput Appl, 29, pp.685~693 (2016)[DOI]
26. Ratner B, "Statistical and machine-learning data mining: techniques for better predictive modeling and analysis of big data", pp.2017, Chapman and Hall
27. Islam MM, "Breast cancer prediction : a comparative study using machine learning techniques", SN Comput Sci, 1, pp.90~ (2020)[DOI]
28. James G, "An introduction to statistical learning", pp.103~ (2013), Springer
29. Guido S, "Introduction to machine learning with python" (2016), O’Reilly Media Inc
30. de Boves Harrington P, "Support vector machine classification trees", Anal Chem, 87(21), pp.11065~11071 (2015)[DOI]
31. Lorena AC, "Comparing machine learning classifiers in potential distribution modelling", Expert Syst Appl, 38(5), pp.5268~5275 (2011)[DOI]
32. Nie F, "Decision Tree SVM : An extension of linear SVM for non-linear classification", Neurocomputing, 401, pp.153~159 (2020)[DOI]
33. Stehman SV, "Selecting and interpreting measures of thematic classification accuracy", Remote Sens Environ, 62(1), pp.77~89 (1997)[DOI]
34. Powers DM, "Evaluation : from precision, recall and F-measure to ROC, informedness, markedness and correlation", Int J Mach Learn Technol, 2, pp.37~63 (2011)
35. Lundberg SM, "A unified approach to interpreting model predictions", Adv Neural Inf Process Syst, pp.4765~4774 (2017)
36. Park JH, "A data-driven approach to a chemotherapy recommendation model based on deep learning for patients with colorectal cancer in Korea", BMC Med Inform Decis Mak, 20, pp.241~ (2020)[DOI]
37. Jin Hyang Jung, "Clinical Value of CEA, CA15-3 and TPS in Breast Cancer", Journal of Korean Breast Cancer Society, 4(2), pp.136~ (2001), Korean Breast Cancer Society[DOI]
38. Giai M, "TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients", Anticancer Res, 16(2), pp.875~881 (1996)
39. Ceylan Z, "Diagnosis of breast cancer using improved machine learning algorithms based on Bayesian optimization", Int J Intell Sys Appl, 8(3), pp.121~130 (2020)[DOI]
40. Hwa HL, "Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models", J Eval Clin Pract, 14(2), pp.275~280 (2008)[DOI]
41. Molina R, "Use of serial carcinoembryonic antigen and CA 15-3 assays in detecting relapses in breast cancer patients", Breast Cancer Res Treat, 36, pp.41~48 (1995)[DOI]
42. Covemey EC, "The clinical value of CEA and CA 15-3 in breast cancer management", Int J BioI Markers, 10(1), pp.35~41 (1995)
43. Haraguchi M, "The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer", Surg Today, 40(8), pp.745~751 (2010)[DOI]
44. Benjapibal M, "Pre-operative prediction of serum CA125level in women with ovarian masses", J Med Assoc Thai, 90(10), pp.1986~1991 (2007)
45. Giordano SH, "Breast cancer treatment guidelines in older women", J Clin Oncol, 23(4), pp.783~791 (2005)[DOI]
46. Tseng YJ, "Predicting breast cancer metastasis by using serum biomarkers and clinicopathological data with machine learning technologies", Int J Med Inform, 128, pp.79~86 (2019)[DOI]
47. Ebeling FG, "Serum CEA and CA 15-3 as prognostic factors in primary breast cancer", Br J Cancer, 86(8), pp.1217~1222 (2002)[DOI]

관련 논문AI추천